International Clinical Trial: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Efficacy and Safety of RB0026 Injection in Preterm and Term Infants in China

Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123076) titled 'A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Efficacy and Safety of RB0026 Injection in Preterm and Term Infants in China' on April 21.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: The First Affiliated Hospital of Guangzhou Medical University

Condition: Respiratory Syncytial Virus Infection

Intervention: RB0026 Injection Solution Group:Single intramuscular injection of 2 ml (200 mg RB0026)

Recruitment Status: Not Recruiting

Phase: 3

Date of First Enrollment: 2024-10-17

Target Sample Size: RB0026 Injection Solution Group...